Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Human Endogenous Retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
The Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis Clinical Trials.
Recommendations for the management of multiple sclerosis relapses.
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
A signal-to-noise-ratio-based analysis of multifocal visual-evoked potentials in multiple sclerosis risk assessment.
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.
Evaluating medically at-risk drivers: a survey of assessment practices in Canada.
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.
Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Disease Suppression Persists With Ozanimod at 72 Weeks in MS
Scrub typhus with longitudinally extensive transverse myelitis.
Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial.
New TYSABRI® data show earlier treatment and longer-term use result in significant reductions in MS disease activity
Tumefactive MS lesions under fingolimod: A case report and literature review.
Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?
Glial contributions to neural function and disease.
Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.

Pages